id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-354972-nc496v6s	Margolin, Emmanuel	Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa	2020-09-10		.txt	text/plain	10919	464	37	As of 8 August 2020, there have been over 1.2 million confirmed cases of COVID-19 in Africa, with 29,833 deaths reported (Africa CDC) There is concern that the pandemic may pose an even greater risk to countries in Africa owing to their weak health-care infrastructure, large burden of co-infections, including HIV-1 and tuberculosis, and ongoing outbreaks of emerging and re-emerging infections such as Ebola virus (Democratic Republic of Congo) and Lassa haemorrhagic fever (Nigeria) that will divert much-needed resources away from the fight against COVID-19 (ref. Given the optimistic development timeline of 12-18 months before any vaccines could be available for widespread use, it is clear that these efforts will not Box 1 | Potential impact of climate on SArS-coV-2 dissemination the comparatively low incidence of coronavirus disease-2019 (COviD19) in africa has raised the possibility that climate could influence the spread of severe acute respiratory syndrome coronavirus 2 (sars-Cov-2).	./cache/cord-354972-nc496v6s.txt	./txt/cord-354972-nc496v6s.txt